mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.2 |
mRNA |
Axitinib |
FIMM |
pan-cancer |
AAC |
0.22 |
0.2 |
mRNA |
BRD-K02251932 |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.2 |
mRNA |
BRD-K48334597 |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.2 |
mRNA |
MI-1 |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.2 |
mRNA |
Fumonisin B1 |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.2 |
mRNA |
myriocin |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.2 |
mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.2 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.2 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.045 |
0.2 |